Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
Apple
AAPL
|
+$935M |
| 3 |
Warner Bros
WBD
|
+$783M |
| 4 |
Home Depot
HD
|
+$626M |
| 5 |
Amazon
AMZN
|
+$476M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$734M |
| 2 |
CERN
Cerner Corp
CERN
|
+$600M |
| 3 |
Marathon Petroleum
MPC
|
+$180M |
| 4 |
PBCT
People's United Financial Inc
PBCT
|
+$169M |
| 5 |
S&P Global
SPGI
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
3501
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $842K | ﹤0.01% |
436,319
-369,794
| -46% | -$807K |
|
3502
Amtech Systems
ASYS
$280M
| $839K | ﹤0.01% |
114,951
+1,775
| +2% | +$15.3K |
|
3503
First Capital
FCAP
$219M
| $839K | ﹤0.01% |
30,986
+4,182
| +16% | +$142K |
|
3504
Algoma Steel
ASTL
$471M
| $837K | ﹤0.01% |
93,349
+37,678
| +68% | +$362K |
|
3505
AquaBounty Technologies
AQB
$7.72M
| $836K | ﹤0.01% |
24,459
-31,839
| -57% | -$972K |
|
|
BBLN
3506
DELISTED
Babylon Holdings Limited
BBLN
| $834K | ﹤0.01% |
+34,120
| New | +$1.49M |
|
3507
Passage Bio
PASG
$14.7M
| $830K | ﹤0.01% |
17,586
-14,680
| -45% | -$686K |
|
3508
Assembly Biosciences
ASMB
$594M
| $828K | ﹤0.01% |
32,882
+1,360
| +4% | +$31.3K |
|
3509
Actinium Pharmaceuticals
ATNM
$30.2M
| $828K | ﹤0.01% |
172,217
+5,045
| +3% | +$28.6K |
|
3510
Precision BioSciences
DTIL
$201M
| $828K | ﹤0.01% |
17,265
-13,229
| -43% | -$777K |
|
3511
Anixa Biosciences
ANIX
$109M
| $826K | ﹤0.01% |
270,003
+779
| +0.3% | +$2.46K |
|
3512
Rush Enterprises Class B
RUSHB
$9.37B
| $826K | ﹤0.01% |
24,990
+4,564
| +22% | +$148K |
|
3513
United Bancorp
UBCP
$89.4M
| $824K | ﹤0.01% |
50,307
+613
| +1% | +$10.5K |
|
|
BIOR
3514
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $816K | ﹤0.01% |
4,668
+54
| +1% | +$11.4K |
|
3515
Asure Software
ASUR
$251M
| $811K | ﹤0.01% |
142,363
+2,453
| +2% | +$14.6K |
|
3516
Phunware
PHUN
$43.4M
| $811K | ﹤0.01% |
15,029
+264
| +2% | +$22.1K |
|
3517
QuickLogic
QUIK
$230M
| $807K | ﹤0.01% |
95,228
+5,578
| +6% | +$34.6K |
|
3518
Stereotaxis
STXS
$137M
| $807K | ﹤0.01% |
438,890
-367,309
| -46% | -$878K |
|
3519
Cytosorbents Corp
CTSO
$22.8M
| $805K | ﹤0.01% |
367,610
-335,105
| -48% | -$769K |
|
3520
NextCure
NXTC
$37.9M
| $803K | ﹤0.01% |
14,251
+1,600
| +13% | +$83.6K |
|
3521
ICICI Bank
IBN
$106B
| $800K | ﹤0.01% |
45,139
+20,145
| +81% | +$377K |
|
3522
Cooper-Standard Automotive
CPS
$484M
| $799K | ﹤0.01% |
160,133
-111,865
| -41% | -$652K |
|
3523
GT Biopharma
GTBP
$10.7M
| $799K | ﹤0.01% |
8,910
-3,170
| -26% | -$240K |
|
3524
Fiverr
FVRR
$324M
| $795K | ﹤0.01% |
23,144
-136,805
| -86% | -$6.5M |
|
3525
Innovative Solutions & Support
ISSC
$407M
| $793K | ﹤0.01% |
110,146
+36,227
| +49% | +$289K |
|
Similar funds
Geode Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
- Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
- Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
- Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
- Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
- Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
- Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.
Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.